On-chip analysis, indexing and screening for chemical producing bacteria in microfluidic static droplet array by Jang, S et al.
Lab on a Chip
PAPER
Cite this: Lab Chip, 2016, 16, 1909
Received 26th January 2016,
Accepted 8th April 2016
DOI: 10.1039/c6lc00118a
www.rsc.org/loc
On-chip analysis, indexing and screening for
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Economic production of chemicals from microbes necessitates development of high-producing strains
and an efficient screening technology is crucial to maximize the effect of the most popular strain improve-
ment method, the combinatorial approach. However, high-throughput screening has been limited for as-
sessment of diverse intracellular metabolites at the single-cell level. Herein, we established a screening
platform that couples a microfluidic static droplet array (SDA) and an artificial riboswitch to analyse intracel-
lular metabolite concentration from single microbial cells. Using this system, we entrapped single
Escherichia coli cells in SDA to measure intracellular L-tryptophan concentrations. It was validated that
intracellular L-tryptophan concentration can be evaluated by the fluorescence from the riboswitch. More-
over, high-producing strains were successfully screened from a mutagenized library, exhibiting up to 145%
productivity compared to its parental strain. This platform will be widely applicable to strain improvement
for diverse metabolites by developing new artificial riboswitches.
Introduction
Chemical production from renewable resources such as bio-
mass is known to be the most promising way to avoid petro-
leum consumption.1 Efficient microbial strains are essential
to accomplish this economic process for the production of
chemicals from biomass, but naturally occurring strains do
not generally perform economical production in terms of the
productivity and yield.2,3 Therefore, strain improvement is
necessary to develop an efficient bioprocess. Due to the com-
plexity of biological systems,4 microbial strains are not easily
redesigned by rational approaches. Accordingly, the combina-
torial approach, which consists of random mutagenesis and
screening, is currently known as the most popular strain im-
provement method.5–7 The success of combinatorial engineer-
ing, however, still depends on the screening method because
it determines the phenotype and performance of the screened
variants.8,9 Technology for the screening of metabolite-
producing microbial cells has requirements such as high-
throughput and wide applicability to diverse molecules.8,10,11
In addition, it would be preferable to evaluate the innate cel-
lular performance in regards to metabolite production with
responses to the culture conditions.
Cellular performance for the production of metabolites
has been conventionally measured by the accumulation of
the target metabolites in the culture medium after several
hours of cultivation. However, metabolite accumulation out-
side the cell does not properly represent the cellular physiol-
ogy for metabolite production at the single-cell level of analy-
sis because the metabolite concentration outside the cell
varies depending on the medium volume, and the reactions
visualizing the metabolites are not generally robust enough
to evaluate cell physiology for metabolite production. There-
fore, in order to evaluate the cellular performance for the pro-
duction of metabolites at the single-cell level, intracellular
metabolite measurement is the more reliable way.
For this reason, dozens of sensors based on biomolecules
have been developed for the detection and measurement of
intracellular metabolites.12–15 Metabolite sensors are generally
composed of biomolecules such as riboswitches and transcrip-
tion factors that specifically bind to the target metabolite and
regulate gene expression upon the binding event. These metabo-
lite biosensors were successfully applied to diverse applications
from elucidation of the regulation mechanism of metabolic path-
ways to the evolution of high metabolite producing strains.16–18
Considering that the creation of a novel riboswitch for the new
target molecule is rather straightforward, biosensor-associated
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measurement of intracellular metabolite should be regarded as a
promising tool for screening with wide applicability.19–21
Signals that reflect intracellular metabolite concentration
could be monitored by fluorescence-activated cell sorting (FACS).
This method is a well-established technology for analysing intra-
cellular fluorescence from a large number of cells and separating
them at the single-cell level. Nonetheless, the viability of the
sorted cells can be negatively affected by numerous factors of
FACS instruments, such as mechanical and physiological stresses
during sorting, making recovery of the desired cells difficult.23
To overcome the aforementioned obstacles, microfluidic
fluorescence-activated droplet sorting (FADS) systems have
been developed because they provide rather mild conditions
for the cells in comparison with FACS.24–26 FADS is able to gen-
erate and monitor picoliter-sized droplets with encapsulated
cells to analyse consumption or production of specific mole-
cules by detection of fluorescence. In this platform, however, it
is difficult to measure the intracellular fluorescence signals di-
rectly from single cells because the size of a microbial cell is
very small to be observed in short period of time in which a
droplet passes by. Moreover, the types of metabolites that can
be detected using this system are restricted to the molecules
that can be linked to fluorescent assay reactions, and conse-
quently, applications for this system are limited. Recently, we
have reported several microfluidic static droplet arrays (SDA) as
a universal analytical platform by combining hydrodynamics
and microvalve technology for generation, manipulation, analy-
sis, and retrieval of multiple microdroplets in parallel.27–30 This
SDA is able to analyse at the single-cell level in real time since
it deals with static droplets with fixed positions. In addition, se-
lective release and retrieval of desired droplets encapsulating
cells and reusability of the system are also attractive features as
a screening method.31,32 We expect that the SDA will solve the
weak points of previously developed FADS.
In this study, we combined the selectively releasable SDA
platform with an artificial riboswitch to set up an efficient
high-throughput screening system that enables quantification
of intracellular metabolite and retrieval of single-cell encapsu-
lated droplets. The SDA device is able to generate the droplet
array with single Escherichia coli cells by individual manipula-
tion of droplets. Furthermore, the droplets containing the de-
sired E. coli cells were selectively extracted after on-chip analy-
sis. The artificial riboswitch that responds to L-tryptophan
allows visualization of the intracellular metabolite and also dif-
ferentiation of the metabolite concentration on the SDA chip.
By integrating the two technologies, we could perform an effi-
cient screening to obtain E. coli strains that have an improved




Phusion DNA polymerase and restriction endonucleases were
purchased from New England Biolabs (Beverly, MA, USA). Oli-
gonucleotides were synthesized by Macrogen (Seoul, Korea)
and are listed in Table S1.† Plasmids were prepared using
AccuPrep Nano-Plus Plasmid Mini Extraction Kit (Bioneer,
Daejeon, Korea). PCR-amplified DNA fragments were purified
using the Expin Gel SV kit (GeneAll Biotechnology, Seoul, Ko-
rea). Counter-Selection BAC Modification Kit for generation
of a genomic mutant library was acquired from Gene Bridges
GmbH (Heidelberg, Germany). Ingredients of cell culture me-
dia for plasmid cloning and chromosomal manipulation were
obtained from BD Biosciences (Sparks, MD, USA). Other re-
agents were purchased from Sigma (St. Louis, MO, USA) un-
less otherwise indicated. The bacterial strains and plasmids
used in this study are listed in Table S2.†
Bacterial strains and plasmids
pMD20-FKFĲf2161) was constructed by subcloning of the
FRT(f2161)-KanR-FRT(f2161) fragment that was amplified by
Phusion polymerase with the f2161_F/R into pMD20 T-vector.
pTrpEfbr was constructed by subcloning of the trpE fragment
amplified from the genomic DNA of Salmonella typhimurium
with styp_trpE_F/R primers into pGFKF2. Point mutation that
confers feedback-resistance was generated by PCR-based site-
directed mutagenesis using mut_trpE_F/R primers. To con-
struct pRpsLneo, the rpsL-neo cassette provided from the
Counter-Selection BAC Modification Kit was amplified with
rneo_F/R and subcloned to the pMD20 T-vector.
All chromosomal work was done by a Red recombination
system using pKD46 and pCP20. To construct the base strain
(SJT0) for L-tryptophan production, rpsL A128G mutation was
generated by direct transformation and recombination of rpsL
A128G oligonucleotide to E. coli W3110. The parental strain
(SJT1) was constructed by, first, deletion of trpR, tnaA, trpE,
and aroG from SJT0 by insertion of FRT-KanR-FRT fragments
amplified with del_trpR_F/R, del_tnaA_F/R, del_trpE_F/R,
del_aroG_F/R, respectively. Three different versions of FRT se-
quences were employed to avoid unwanted interactions be-
tween FRT sequences on the chromosome. The wild type FRT
sequence was applied for deletion of aroG, the F72 mutant for
trpR and trpE, and the F2161 mutant for tnaA, respectively.
Then, the native aroG was replaced by the PCR fragment of
pAroGfbr amplified with ins_aroG_F/R and the native trpE by
the PCR fragment of pTrpEfbr amplified with del_trpE_F and
ins_trpE_R. Finally, the native promoter of tktA was replaced by
PBBa_J23100 and a redesigned 5′-untranslated region (UTR) using
the FRT-KanR-FRT (WT) fragment amplified with ins_tktA_F/R.
The random UTR sequence library for chromosomal ppsA was
generated utilizing the Counter-Selection BAC Modification Kit.
The rpsL-neo cassette was amplified from pRpsLneo with
pr_ppsA_F/R and recombined to the promoter-UTR region of
ppsA of the SJT1 strain. The successful recombinant was named
SJT10 and was resistant to kanamycin while sensitive to strepto-
mycin due to the coexistence of mutant and wild-type rpsL. Then
the oligonucleotide ppsA_UTR Library was directly transformed
and recombined to the SJT10 to replace the rpsL-neo cassette. The
recombinants were grown on streptomycin-supplemented agar
plates since the wild type rpsL was removed by the recombina-
tion, and the resistance to streptomycin was conferred on the cell
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by the mutant rpsL in successful recombinants.33 Then, the
pTrpRibo plasmid was transformed to the resulting recombinants
for construction of the library to be screened on a chip.
Fabrication of the SDA device
The SDA device was fabricated by a multi-step soft lithography
process to integrate microvalves using polydimethylsiloxane
(PDMS) (Sylgard 184, Dow Corning, MI, USA). Three different
master molds were fabricated by photolithography to generate
the fluidic, control, and block layers. The fluidic layer master
was created on a silicon wafer by spinning an SU-8 3025 nega-
tive photoresist (Microchem Corp, Newton, MA) at a thickness
of 20 μm and patterned by photolithography. The control layer
and block layer master were patterned in the same way and
the thickness was 20 μm. The mixture of PDMS prepolymer
and its curing agent (10 : 1 ratio) were poured onto the master
mold for the fluidic layer, cured in a 65 °C oven for 60 min,
and peeled off from the master mold; injection holes were
then punched into the fluidic layer. The bottom pneumatic
microvalve layer was formed on the master mold by spin-
coating the PDMS mixture (20 : 1 ratio of the prepolymer and
curing agent) at 3000 rpm for 1 min and curing at 65 °C for
45 min. Then, the fluidic layer was aligned over the microvalve
layer and cured in a 65 °C oven for 50 min. After that, the two-
layered PDMS slab was attached onto the master mold for the
block layer and cured in a 65 °C oven overnight. The PDMS
chip with the fluidic, control, and block layers were peeled off
from the master mold, and some holes were generated to con-
nect the inlet ports to the microvalve channels using biopsy
punch. Finally, the PDMS chip was bonded to a glass slide by
plasma treatment for 1 min and then kept in a 65 °C oven
overnight to improve the bonding strength.
Operation of the SDA device
The microfluidic device was operated by solenoid valve mani-
folds and a controller (Stanford Microfluidics Foundry, USA).
A USB controller-mounted computer controlled the switching
of the 3-way solenoid valves of the manifolds. A custom-built
LabVIEW program was used to switch the individual on-chip
microvalves. Nitrogen gas was used to inject the reagents into
the microchannels and microvalves. Before operating the device,
we filled some distilled water in the microvalve channels under
0.30 MPa. FC-40 oil with 30% 1H,1H,2H,2H-perfluorooctanol as
the continuous phase and aqueous solutions for the dispersed
phase were injected into the microchannels. First, we optimized
the droplet generating conditions with all control valves turned
off. The experimental pressure was 0.10 MPa and 0.12 MPa for
oil and aqueous phase injections, respectively. For trap-and-
release of droplets, 0.2 MPa and 0.3 MPa were applied to the
control and block valves. To handle a 3 × 8 array, we used eight
and three inlet ports to control and block the valves. Control
valves were expanded to entrap the generated droplet in array
chambers and the three block valves barricaded each array row
to freeze the control valves on demand so that a desired droplet
can selectively be extracted from the droplet array without any
interference from other droplets (Fig. 1A).
Screening of the bacteria library
The bacterial solution was diluted to an appropriate optical den-
sity (O.D.600) and introduced into the sample inlet on the fluidic
channel, and the other sample channel was filled with PBS buffer.
Single-cell encapsulated droplets with a diameter of 100 μm were
trapped sequentially in array chambers and imaged to analyse the
intensity of sGFP fluorescence from bacteria-occupied areas using
a fluorescence microscope (Eclipse Ti-E, Nikon, Japan) equipped
with a 488 nm argon-ion laser and a PMT with GFP filter and NIS
Elements software (Nikon, Japan). Then, we calculated sGFP fluo-
rescence intensity per unit area to determine the intracellular L-
tryptophan concentration of each single-cell. The cells with the
highest ANFI values were retrieved from the SDA and grown on
LB-agar plates (Cm). Promoter and 5′-UTRs of the cells were am-
plified by PCR with chk_ppsA_F/R and sequenced using the same
primer set.
Tryptophan production and detection of metabolites
The base strain (SJT0), the parental strain (SJT1), and the three
chip-screened strains (SJT11, SJT12, SJT13) were grown for
24 hours in M9 minimal medium supplemented with 4 g L−1
glucose and 34 μg ml−1 chloramphenicol (Cm). The cultures
were diluted to an O.D.600 of 0.05 in the same medium until
reaching an O.D.600 of 0.8 to prepare fresh seeds. The seed cul-
tures were inoculated 30 mL of the same medium in 300 ml
flasks to a final O.D.600 of 0.05 and incubated at 37 °C with shak-
ing (250 rpm).
Concentrations of accumulated L-tryptophan and consumed
glucose in culture broth were analysed using an Ultimate 3000 an-
alytical high-performance liquid chromatography (HPLC) system
(Dionex, Sunnyvale, CA, USA) equipped with appropriate columns.
The concentration of L-tryptophan was determined by a pre-
column derivatization method using o-phthalaldehyde.34 The
derivatized samples were eluted with a gradient of acetonitrile,
methanol, and water (v/v% 45 :45 :10) and 50 mM sodium acetate
buffer (pH 6.5) at a flow rate of 1.5 ml min−1 through an Acclaim
120 C18 reverse-phase column (Dionex) maintained at 40 °C, and
monitored by an ultraviolet-visible diode array detector at 338
nm. The concentration of glucose was measured with an
Aminex HPX-87H column (Bio-Rad Laboratories, Richmond,
CA, USA) maintained at 65 °C. The samples were eluted with
5 mM H2SO4 at a flow rate of 0.6 ml min
−1 and monitored by
a Shodex RI-101 detector (Shodex, Klokkerfaldet, Denmark).
Results and discussion
Generation of the static droplet array with entrapped single
cells for screening
Screening of metabolite-producing microbial strains from a
library comprises measurement of the target metabolite from
each constituent cell and selective retrieval of the desired
cells. It is especially preferable to analyse the intracellular
metabolite concentration at the single-cell level to properly
evaluate the cellular performance for the production of target
metabolite. In this study, we screened an E. coli library for L-
tryptophan production using an SDA device consisting of
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three layers: fluidic layer for generating and guiding of
droplets, control layer for trapping and releasing of the
droplets, and a blocking layer for freezing the control valves
(Fig. 1A). The three layers were assembled to construct a 3 × 8 ar-
ray chamber within 1.8 mm × 2.6 mm to trap droplets on a chip.
The first step for screening of bacterial strains with high
metabolite production was to spatially separate library cells
before analysing the metabolite concentration. Therefore, we
demonstrated the generation of the single-cell droplet array
by selective droplet manipulation that was previously
reported. We adequately diluted the pre-cultured bacteria to
maximize the number of single-cell encapsulated droplets
according to Poisson's law22 and injected the bacterial solu-
tion into the SDA device. 100-picoliter mono-disperse drop-
lets containing cells were generated and moved to the array
region while control valves were on. The cells encapsulated in
each droplet were visualized by sGFP encoded by the plasmid
in the cells. Since the number of cells stored in droplets fol-
lows Poisson's law, the chambers with multiple cells should
be replaced with single-cell droplets by repeating the selective
releasing and refilling manipulations while other single-cell
droplets remain intact. (Fig. 1B). In general, based on our pro-
cedure, the generating time of the single-cell array consisted of
three steps: formation of droplet array containing 24 droplets
(5 seconds), analysis and selective release of undesired drop-
lets (2 seconds), and droplet re-filling into array (1 second).
Consequently, it takes an average of 15 seconds to generate
the single cell array after an average number of repetitions
Fig. 1 Illustration of a SDA device for single cell sorting. (A) Macro-structure of the SDA device and 3D rendering image with three valve types;
droplet generation valve, control valve, and block valve. (B) Sequential scheme of repetitive manipulation for generating a single-cell array: droplet
filling, wasting droplet with multi-cells, and droplet re-filling. (C) Procedure for the sorting of high chemical-producing cells by selective releasing
of droplets based on area-normalized fluorescence intensity.
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(n = 5), including selective removing of undesired droplets (2 s)
and refilling cell-encapsulating droplets (1 s). Therefore, the
droplet array system is able to analyze 4320 cells per hour be-
cause the analysis of 24 droplets consumes 20 seconds.
Fig. 1C shows our screening procedure in the SDA based on
fluorescence signal intensity. As a selection parameter, we
analysed the fluorescent signal intensity normalized by the area
occupied by a single bacterial cell (ANFI, area-normalized fluo-
rescence intensity) in the generated droplet array. After that, the
ANFI values were indexed by the location of array chamber in
the 3 × 8 array to recognize the desired single cells. Single cells
whose ANFI was higher than a certain pre-defined threshold
were selectively released into the collection chamber to be
harvested. Otherwise, the encapsulated cells with lower values
were wasted (Fig. 1C and S1†).
Fluorescence-based measurement of intracellular metabolite
concentration
Intracellular concentration of the target metabolite should be
easily measured to screen a large library efficiently. In that re-
gard, the optical detection method using fluorescent protein
is one of the best approaches for high-throughput screening.
Therefore, we applied an artificial riboswitch, which is able to ac-
tivate the expression level of sGFP in response to L-tryptophan,13
for on-chip visualization and quantification of L-tryptophan
in this study. To utilize the riboswitch for quantification of
L-tryptophan, functionality and dose–response curves of the
riboswitch were validated using the SDA device.
E. coli W3110 was transformed with the plasmid that en-
codes the riboswitch and cultured in M9 (Cm) supplemented
with 0, 0.01, 0.05, 0.1, 0.5, and 1 g L−1 of L-tryptophan for 4
hours to adjust and stabilize the expression level of sGFP for
each L-tryptophan concentration. Extracellular L-tryptophan
can be readily transported across the cell membrane through a
set of transporters35 and activate the riboswitch inside the cell.
Next, the cells were injected into the SDA device to create the
single-cell SDA as described in the materials and methods sec-
tion. Then, we measured ANFI from about fifty single cells in
the droplets for each L-tryptophan concentration and the mea-
sured ANFI values were averaged. As anticipated, the ANFI in-
creased as concentration of the supplemented L-tryptophan in-
creased, displaying a sigmoidal dose–response curve (Fig. 2).
Accordingly, the riboswitch enabled distinction of different
intracellular L-tryptophan concentrations based on the ANFI,
and the dose–response curve was used as a criterion for
screening of the E. coli library.
Analysis and screening of a bacteria library
We combined the single-cell SDA and the riboswitch for screen-
ing of an E. coli library whose L-tryptophan productivity was di-
versified. Specifically, the 5′-UTR of chromosomal ppsA of SJT1
(see section 2.2) was randomized to modulate its expression
levels; as a result, metabolic flux towards L-tryptophan biosyn-
thesis was diversified in this library (Fig. 3A). Next, the library
transformed with the riboswitch plasmid was cultured
Fig. 2 Dose–response curve between L-tryptophan concentration and
ANFI of single cells generated by the riboswitch. L-Tryptophan was added
to the medium at concentrations of 0, 0.01, 0.05, 0.1, 0.5 and 1 g L−1.
About fifty single cells were analysed for each L-tryptophan concentration.
Fig. 3 (A) Metabolic pathway towards L-tryptophan in E. coli (right):
phosphoenolpyruvate (PEP), pyruvate (PYR), acetyl-CoA (AcCoA),
D-erythrose 4-phosphate (E4P), 3-deoxy-D-arabino-heptulosonate-7-
phosphate (DAHP), shikimate (SHIK), chorismate (CHA), prephenate
(PPA), 2-oxo-3-phenylpropanoate (PPY), L-phenylalanine (L-Phe),
4-hydroxyphenylpyruvate (HPP), L-tyrosine (L-Tyr), anthranilate (ANTA),
and (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate (I3GP). Thick, red ar-
rows indicate target genes whose expression were amplified by the
synthetic promoter and redesigned 5′-UTRs: phosphoenolpyruvate
synthase (ppsA), transketolase (tktA), 3-deoxy-D-arabino-
heptulosonate-7-phosphate synthase, feedback-resistant (aroGfbr), an-
thranilate synthase, and feedback-resistant (trpEfbrD). Expression level
of ppsA was diversified by randomizing its 5′-UTR sequence. Se-
quences of ppsA 5′-UTRs from the screened variants are shown (left).
(B) Cell population distribution of ANFI before sorting and (C) after
sorting. The results (B) were obtained from the analysis of 4231 total
cells in 1 hour to investigate a population distribution showing different
ANFIs on the SDA device.
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overnight, and sub-cultured for 5 hours, to prepare fresh cells
with a distinctive fluorescence intensity distribution as a conse-
quence of the diversified L-tryptophan productivity. Then, we
analysed 4231 total cells to investigate a population distribution
of diversified ANFIs on the SDA device. The cells were collected
in the “collection chamber”, which is shown in Fig. S1,† after
droplet generation with cells. The top 10% of the population,
which is roughly 423 cells, showed ANFIs of 51–65 a.u. μm−2,
and only 83 bacteria corresponding to the top 2% exhibited
values of above 60 a.u. μm−2 (Fig. 3B). We selectively retrieved
51 droplets harbouring single cells into the chamber whose
ANFI was above 50 a.u. μm−2 from observation of over 4000
single-cell droplets utilizing the plot shown in Fig. 2 and 3B.
The fluorescence intensity distribution of the selected cells
was analysed to corroborate screening efficiency of our system.
We obtained a population where 100% of the cells of the popula-
tion displayed an ANFI above 50 a.u. μm−2 and 31% of cells
showed above 60 a.u. μm−2. This result indicates that we success-
fully enriched the library towards high fluorescence intensity,
reaching an increase in over 833% of the proportion of cells
whose ANFI is over 50 a.u. μm−2, and 1500% increase whose
value is larger than 60 a.u. μm−2 compared to the starting popu-
lation. Collectively, the single-cell SDA and the riboswitch were
successfully coupled to analyse the fluorescence intensity of the
E. coli population and to enrich the population towards a spe-
cific direction, namely, high L-tryptophan production.
Chemical production from the screened bacteria
We acquired three screened cells whose ANFI were 58.6, 61.4,
and 63.2. It was confirmed that the sequences of promoter
and 5′-UTRs of the isolated cells were consistent with the de-
sign of the library (Fig. 3A). The cells were cultured to con-
firm that the L-tryptophan productivity of the enriched cells
was improved in comparison with the wild type and the pa-
rental strain. The SJT0, SJT1, and the three screened strains
(SJT11, SJT12, and SJT13) were cultured to validate the L-
tryptophan production. Each strain was inoculated in 30 mL
of M9 (Cm) and cultured at 37 °C with shaking at 250 rpm.
At first, L-tryptophan was not detected from the culture broth
Fig. 4 ĲA)–(C) HPLC measurements from the flask culture of E. coli strains. Tryptophan production, O.D.600, and consumption of glucose of the E.
coli (A) wild type, (B) parental strain, and (C) chip-screened strains were represented by red triangles, black open circles, and green squares, re-
spectively. Briefly, each strain was inoculated to 30 mL of M9 (Cm) medium in a 300 mL flask. Metabolites in the culture broth were detected using
HPLC. Detailed procedure for the flask culture and metabolite measurements are explained in the experimental section. (D) L-Tryptophan specific
productivity of the E. coli strains whose ANFI were 58.6, 61.4 and 63.1.
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of SJT0, whereas SJT1 produced 0.045 ± 0.0034 g L−1 in 24
hours (Fig. 4A, Table S3†). Moreover, all the three screened
strains showed improved L-tryptophan production, reaching
up to 0.065 ± 0.0084 g L−1, which corresponds to a 45.4% in-
crease compared to SJT1 (Fig. 4A, Table S3†). Moreover, the
screened strains were enhanced in terms of the specific pro-
ductivity that quantifies the production rate normalized by
the cell mass. Interestingly, the measured ANFI of each strain
could be used to estimate the specific productivity since both
values were normalized by the number of cells (Fig. 4B). In
the meantime, the specific growth rate of SJT1 was decreased
compared to SJT0, and the rates of SJT11, SJT12, and SJT13
were decreased even further (Table S3†). The cell growth can
be negatively affected by the production of L-tryptophan be-
cause this pathway consumes PEP, one of the intermediates
of the central carbon metabolism that has a pivotal role in
the generation of building blocks and energy materials for
cell growth (Fig. 3A).36,37 This result emphasizes again that
high-throughput screening is necessary to find an optimum
where L-tryptophan production and cell growth are well-bal-
anced. Taken altogether, the SDA device, combined with the
artificial riboswitch, was able to efficiently screen improved L-
tryptophan producer strains based on its ability to manipu-
late single cells and to visualize intracellular metabolites.
Conclusions
Herein, we established a screening method that could enrich
bacterial strains with high metabolite production based on
optical analysis at the single-cell level. The SDA device and
the artificial riboswitch were joined together for quantitative
visualization of intracellular L-tryptophan, on-chip analysis,
indexing, and selective retrieval of single cells. We were able
to readily investigate a dose–response curve of the riboswitch
and fluorescence population of the mutagenized E. coli li-
brary using this method. Bacterial cells with high concentra-
tions of intracellular L-tryptophan were screened employing
the dose–response curve and the fluorescence population as
selection criteria. Efficiency of the enrichment reached up to
1500%, and most of the screened cells belonged to the
highest quartile of the population. The titer of L-tryptophan
from the screened variants was increased to 145% in compar-
ison with the parental strain; and the specific productivity
was also improved.
Our method provides several advantages over conventional
screening technologies. Unnecessary use of large amount of
culture medium and consumables could be avoided thanks
to the capability of analysing metabolites at the single cell
level. Selective manipulation and indexing guarantees only
the desired cells are collected for further study. Unwanted
growth impairment can be prevented as well since the SDA
device offers mild conditions for the cells. Furthermore, this
method may be extended to a wide variety of chemicals con-
sidering that riboswitch-based metabolite sensors could be
easily engineered through a variety of synthetic biology
techniques.
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